Literature DB >> 6729844

Transfer of ricin toxicity by spleen cells.

D P McIntosh, D C Edwards, A J Davies.   

Abstract

The ability of spleen cells to internalise ricin and release it in a form capable of killing an untreated cell population has been studied. Potential donor cells were incubated with a range of ricin concentrations and the amount of ricin subsequently released was found to be related to the ricin concentration of the primary incubation. Ricin release was detected either by using radiolabelled toxin or by measuring its cytotoxic effects. Cells which, after incubation with ricin, were washed with lactose or anti-ricin IgG had a slightly reduced ability to transfer the toxin to other cells, suggesting that much of the ricin had been internalised by the donor cells. The presence of 100 mM lactose in the incubation medium was unable to inhibit the uptake of ricin and did not prevent the release of competent toxin. Cells carrying the toxic material were lethal to animals and in vitro the released toxin was as susceptible to inactivation by anti-ricin IgG as was free ricin.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6729844     DOI: 10.1016/0041-0101(84)90029-1

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  7 in total

1.  Intracellular trafficking of AIP56, an NF-κB-cleaving toxin from Photobacterium damselae subsp. piscicida.

Authors:  Liliana M G Pereira; Rute D Pinto; Daniela S Silva; Ana R Moreira; Christoph Beitzinger; Pedro Oliveira; Paula Sampaio; Roland Benz; Jorge E Azevedo; Nuno M S dos Santos; Ana do Vale
Journal:  Infect Immun       Date:  2014-10-06       Impact factor: 3.441

2.  The carriage and delivery of substances to lymphatic tissues by recirculating lymphocytes. I. The concentration of ricin in lymphocyte traffic areas.

Authors:  S M Sparshott; J A Forrester; D P McIntosh; C Wood; A J Davies; W L Ford
Journal:  Immunology       Date:  1985-04       Impact factor: 7.397

3.  Antitumour efficacy of lymphokine-activated killer cells loaded with ricin against experimentally induced lung metastases.

Authors:  P Zanovello; A Rosato; V Bronte; S Mandruzzato; V Cerundolo; D Collavo
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

4.  Galactosylated glycan expression and macrophage sensitivity of Lewis lung tumor cells with different metastatic phenotype.

Authors:  J Tímár; A Ladányi; K Lapis; E Moczar
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

5.  The effect of ricin B chain on the intracellular trafficking of an A chain immunotoxin.

Authors:  J Timar; D P McIntosh; R Henry; A J Cumber; G D Parnell; A J Davies
Journal:  Br J Cancer       Date:  1991-10       Impact factor: 7.640

6.  Lymphocyte targeted ricin as a potential therapy for lymphoid malignancy. I. Targeting efficiency.

Authors:  C S Ramsden; M T Drayson; E B Bell
Journal:  Br J Cancer       Date:  1991-05       Impact factor: 7.640

7.  Temporary inhibition of Moloney-murine sarcoma virus (M-MSV) induced-tumours by adoptive transfer of ricin-treated T-lymphocytes.

Authors:  V Cerundolo; P Zanovello; D McIntosh; R Fabbris; A J Davies; D Collavo
Journal:  Br J Cancer       Date:  1987-04       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.